Dec. 8, 2011—Compounds developed at Vanderbilt could offer a whole new way to treat atherosclerosis.
Dec. 1, 2011—Structural biology studies of a bacterial protein suggest a new target for treating life-threatening heart infection.
Oct. 28, 2011—Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.
Oct. 21, 2011—Bipolar depression and schizophrenia share patterns of changes in neurons that regulate information flow, new research shows.
Sep. 22, 2011—The discovery of new compounds that work in a fundamentally different way than those in existing schizophrenia medications may allow for more normal function of brain cells involved in schizophrenia.
Sep. 15, 2011—Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.
Aug. 30, 2011—In addition to her high school diploma, Aziza Hart earned an unusual honor this spring – her first scientific paper was published in a new Vanderbilt University journal, Young Scientist. Hart, who graduated from Nashville’s Glencliff High School, spent part of her senior year in a Vanderbilt laboratory, studying a brain abnormality that could lead...
Aug. 16, 2011—A certain signaling pathway could be key to improving cardiac repair after a heart attack.
Jul. 29, 2011—Abnormalities of the hippocampus, a seahorse-shaped brain region involved in learning and memory, may play a role in the psychotic symptoms and cognitive deficits of schizophrenia.
Jul. 21, 2011—A new understanding of the biochemical pathway that builds our skin barrier could lead to treatments for skin diseases.
Jun. 24, 2011—Cocaine exposure during the teen years causes long-lasting brain and behavioral changes in rats.
May. 9, 2011—Discovery of a new class of insect repellant raises the possibility of formulations that are thousands of times more effective than current repellants.